Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GPI-1485 (GM1485) (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 247.00 | |
25 mg | In stock | $ 455.00 | |
50 mg | In stock | $ 672.00 | |
100 mg | In stock | $ 956.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 178.00 |
Description | GPI-1485 (GM1485) (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke. |
In vitro | GPI-1485 induced cellular reprogramming and neural cell induction in normal human dermal fibroblasts (NHDF) [1]. |
In vivo | GPI-1485 (5 mg/kg; intraperitoneal injection; 6-week period of daily) improved long-term neurological recovery in rats |
Synonyms | GM1485 |
Molecular Weight | 241.28 |
Formula | C12H19NO4 |
CAS No. | 186268-78-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (393.73 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GPI-1485 186268-78-0 Others neurofunctional GPI1485 regeneration Inhibitor ligand stroke GM 1485 GPI 1485 inhibit immunophilin neural GM-1485 GM1485 inhibitor